Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 70 sec. here
  • 19 min. at publisher
  • 📊 Quality Score:
  • News: 87%
  • Publisher: 71%

Medicine News

Sanfilippo Syndrome,Syndrome,Children

As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including pain, loss of speech, extreme agitation, and distress, gastrointestinal symptoms, and profound sleep disturbance.

The Lundquist InstituteJun 21 2024 With no approved treatment, clinical specialists have had few options to help alleviate this suffering until now.

Sanfilippo syndrome, also known as mucopolysaccharidosis type III , is considered an orphan disease, which classifies it for special considerations in drug development and policy. It is a rare genetic disorder in which the body is unable to break down the complex molecule heparan sulfate. Accumulation of heparan sulfate in cells then triggers several biological consequences, including inflammation, ultimately leading to progressive dementia and body-wide disease.

Dr. Lynda Polgreen, the study's principal investigator, expressed optimism about the results, "The changes we observed in our patients represent significant improvements in the day-to-day lives of individuals with Sanfilippo syndrome and their families. This trial highlights the potential of anakinra as an adjunctive treatment option and underscores the broader importance of targeting downstream effects, such as inflammation, in lysosomal diseases.

"Funding provided by Cure Sanfilippo Foundation to support all clinical trial activities and patient travel was made possible by generous donors and families who support the Foundation's mission; creating new opportunities to transform lives. We look forward to partnering with The Lundquist Institute to advance additional clinical programs," said Cure Sanfilippo Foundation President and Co-Founder Glenn O'Neill.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Sanfilippo syndrome: Research team resolves structure of crucial enzyme for the first timeFor the first time, a team co-led by CHU Sainte-Justine researcher and professor in the Faculty of Medicine at Université de Montréal, Alexey Pshezhetsky has succeeded in resolving the unique structure of the HGSNAT enzyme, a deficiency of which causes Sanfilippo syndrome, a rare pediatric disease affecting the central nervous system.
Source: medical_xpress - 🏆 101. / 51 Read more »

Clinical trial reports promising new treatment reduces suffering in Sanfilippo syndromeAs a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including pain, loss of speech, extreme agitation, and distress, gastrointestinal symptoms, and profound sleep disturbance.
Source: medical_xpress - 🏆 101. / 51 Read more »

Megan McKenna shows off bare baby bump as she shows off her baby moving...Pregnant Megan McKenna issued urgent warning by fans after medical emergency hell in Dubai
Source: TheSun - 🏆 64. / 61 Read more »

Proof-of-concept study shows sweat health monitor can measure levels of disease markersA wearable health monitor developed by Washington State University researchers can reliably measure levels of important biochemicals in sweat during physical exercise.
Source: medical_xpress - 🏆 101. / 51 Read more »